Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Bullboard - Stock Discussion Forum Soligenix Inc SNGX

Healthcare Biotechnology

Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Its Specialized BioTherapeutics segment is developing and focused on the commercialization of HyBryte (a proposed name of SGX301), a novel photodynamic therapy (PDT), utilizing topical synthetic hypericin activated with safe... see more

Add To Watchlist

Bullboard (NDAQ:SNGX)

View:

Post by 10QKingon Oct 03, 2024 10:11am

SGNX WHO Says Risk of Marburg Virus Outbreak

SGNX WHO Says Risk of Marburg Virus Outbreak Very High at National Level

Post by whytestockson Sep 20, 2024 11:31am

Nova Minerals and Soligenix Interviews to Air on the RedChip

JUST IN: $SNGX Nova Minerals and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TVORLANDO, FL / ACCESSWIRE / September 20, 2024 / RedChip Companies will air ...more

BioVaxys' DPX Exhibits Superior Immune System Activation Compared to Aqueous and Emulsion-Based Antigen Delivery Systems

posted Oct 31, 2024 9:00am by BioVaxys Technology Corp.

"BioVaxys is at the forefront of a significant shift in the drug delivery landscape," James Passin, CEO of BioVaxys, stated, "These groundbreaking study results validate our strategic position in an important segment of the multi-billion drug delivery market. DPX not only outperforms current antigen delivery solutions but also demonstrate ...read more

Post by MikeTesteron Aug 03, 2024 11:39am

Soligenix, Inc. (NASDAQ:SNGX): Positive Interim Results for

https://beyondspx.com/2024/08/02/soligenix-inc-nasdaqsngx-positive-interim-results-for-hybryte-in-investigator-initiated-study-in-ctcl-raising-valuation-to-35-per-share/

Post by whytestockson Jul 15, 2024 6:16pm

PRISM MarketView Features Q&A with Dr. Ellen Kim: Soligenix'

BREAKING NEWS: $SNGX PRISM MarketView Features Q&A with Dr. Ellen Kim: Soligenix's HyBryte(TM)- Lighting the Way Towards Commercial Success with Promising FLASH Study ResultsNEW YORK, July 15, ...more

(0)
•••

Post by PressReleaseon Jun 14, 2024 7:30am

New Press Release - A Comparison of Vaccine Technologies to be Presented at the ASM Microbe Conference

Advanced subunit vaccine technology, including SuVax™ and MarVax™, to be discussed alongside mRNA and viral vectored vaccine approachesPRINCETON, N.J., June 14, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on...read article.

(0)
•••

Post by PressReleaseon Jun 07, 2024 9:01am

New Press Release - Soligenix and Sharps Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESSWIRE / June 7, 2024 / RedChip Companies will air interviews with Soligenix, Inc. (Nasdaq:SNGX) and Sharps Technology Inc. (Nasdaq:STSS) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, June 8, at 7 p.m. Eastern Time (ET...read article.

(0)
•••

Post by PressReleaseon May 31, 2024 7:30am

New Press Release - Soligenix Announces Reverse Stock Split

Common Stock Will Begin Trading on Split-Adjusted Basis on June 6, 2024PRINCETON, N.J., May 31, 2024 /PRNewswire/ -- Soligenix, Inc. (NASDAQ: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where...read article.

(0)
•••

Post by PressReleaseon May 29, 2024 7:30am

New Press Release - Soligenix Encourages Stockholders to Vote their Shares at the Annual Meeting

Most shareholders can vote by calling 1-833-782-7145Only one day left to votePRINCETON, N.J., May 29, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases...read article.

(0)
•••

Post by PressReleaseon May 24, 2024 7:30am

New Press Release - Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting

PRINCETON, N.J., May 24, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its 2024 Annual...read article.

(0)
•••

Post by PressReleaseon May 23, 2024 7:30am

New Press Release - Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split

Most shareholders can vote by calling 1-833-782-7145PRINCETON, N.J., May 23, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet...read article.

(0)
•••

Post by PressReleaseon May 21, 2024 7:30am

New Press Release - SuVax(TM) and MarVax(TM) Thermostable Vaccine Platform to be Presented at the Vaccine Technology IX Conference

PRINCETON, N.J., May 21, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that Professor Axel...read article.

(0)
•••

Post by PressReleaseon May 20, 2024 7:30am

New Press Release - Soligenix Encourages Stockholders to Vote Prior to Annual Meeting

Annual Meeting to be held May 23, 2024PRINCETON, N.J., May 20, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need...read article.

(0)
•••

Post by PressReleaseon May 16, 2024 7:30am

New Press Release - Positive Clinical Results from HyBryte(TM) Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice

Published Results Confirm and Extend Response Results from Phase 3 FLASH StudyPRINCETON, N.J., May 16, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases...read article.

Post by whytestockson May 10, 2024 10:45pm

Soligenix Announces Recent Accomplishments And First Quarter

News; $SNGX Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial ResultsSoligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results PR Newswire PRINCETON ...more

(0)
•••

Post by PressReleaseon May 10, 2024 7:30am

New Press Release - Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results

PRINCETON, N.J., May 10, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent...read article.

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

< Previous

Next >

Dealroom for high-potential pre-IPO opportunities

Become a member today, It's free!

Bullboard - Stock Discussion Forum Soligenix Inc SNGX

Bullboard (NDAQ:SNGX)

SGNX WHO Says Risk of Marburg Virus Outbreak

Nova Minerals and Soligenix Interviews to Air on the RedChip

BioVaxys' DPX Exhibits Superior Immune System Activation Compared to Aqueous and Emulsion-Based Antigen Delivery Systems

Soligenix, Inc. (NASDAQ:SNGX): Positive Interim Results for

PRISM MarketView Features Q&A with Dr. Ellen Kim: Soligenix'

New Press Release - A Comparison of Vaccine Technologies to be Presented at the ASM Microbe Conference

New Press Release - Soligenix and Sharps Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

New Press Release - Soligenix Announces Reverse Stock Split

New Press Release - Soligenix Encourages Stockholders to Vote their Shares at the Annual Meeting

New Press Release - Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting

New Press Release - Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split

New Press Release - SuVax(TM) and MarVax(TM) Thermostable Vaccine Platform to be Presented at the Vaccine Technology IX Conference

New Press Release - Soligenix Encourages Stockholders to Vote Prior to Annual Meeting

New Press Release - Positive Clinical Results from HyBryte(TM) Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice

Soligenix Announces Recent Accomplishments And First Quarter

New Press Release - Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results

Featured News Links

Tribe Property Technologies Provides Update on Tribe Home, Demonstrating Increased Efficiencies with Property Management Platform

Learn how to Trade on the U.S. Election and other Economic and Environmental Events

Major Copper-Gold Discovery Revealed! High-Grade Rock Samples Signal Untapped Potential

Canadian Miner Launches Private Placement for Ambitious Alaskan Gold Project

Be a Part of a Gold Company Before it Catches the Attention of the Market’s Major Players

A Swedish Solution to Break European Dependency on China for Critical Raw Materials

Breakthrough in Cancer Vaccine Tech: New Platform Outshines Traditional Methods in Immune Activation

Prospera Energy corporate update: 3 years of strategic restructuring, recovery and future growth

Discover Options Trading Strategies to Minimize your Tax Burden

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard - Stock Discussion Forum Soligenix Inc SNGX

Join the community and start posting on the bullboards today. It's free.

Create a portfolio watchlist today. It's free.

Bullboard (NDAQ:SNGX)

Featured News Links